Status:
COMPLETED
Evaluation of Advanced US Tools in Assessing Allograft Complications
Lead Sponsor:
Imperial College London
Conditions:
Renal Failure
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the role of advanced US technology in assessing renal transplants as screening tools such as 3D Ultrasound, Ultrasound SWE, and MFI besides current ultrasound conventional metheds...
Detailed Description
This study will focus on monitoring renal after transplantation using all US advanced technology. Aim one will concentrate on the 3D US in assessing artery stenosis (TRAS) compared to the gold standa...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Patients ≥ 18 years.
- Tx patients.
- Gender.
- EXCLUSION CRITERIA
- Prisoners.
- Patients \< 18 years.
- Pregnant women
Exclusion
Key Trial Info
Start Date :
January 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04423458
Start Date
January 4 2022
End Date
September 30 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College London
London, United Kingdom, W12 0HS